149 related articles for article (PubMed ID: 37614621)
1. Targeted Protein Degradation through Recruitment of the CUL4A Complex Adaptor Protein DDB1.
Meyers M; Cismoski S; Panidapu A; Chie-Leon B; Nomura DK
bioRxiv; 2023 Aug; ():. PubMed ID: 37614621
[TBL] [Abstract][Full Text] [Related]
2. Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1.
Meyers M; Cismoski S; Panidapu A; Chie-Leon B; Nomura DK
ACS Chem Biol; 2024 Jan; 19(1):58-68. PubMed ID: 38192078
[TBL] [Abstract][Full Text] [Related]
3. Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation.
Hong SH; Osa A; Huang OW; Wertz IE; Nomura DK
bioRxiv; 2023 Nov; ():. PubMed ID: 37904950
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation.
Hong SH; Divakaran A; Osa A; Huang OW; Wertz IE; Nomura DK
ACS Chem Biol; 2024 Feb; 19(2):442-450. PubMed ID: 38305738
[TBL] [Abstract][Full Text] [Related]
5. Targeted Protein Degradation through E2 Recruitment.
Forte N; Dovala D; Hesse MJ; McKenna JM; Tallarico JA; Schirle M; Nomura DK
ACS Chem Biol; 2023 Apr; 18(4):897-904. PubMed ID: 36940189
[TBL] [Abstract][Full Text] [Related]
6. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
Belcher BP; Ward CC; Nomura DK
Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
[TBL] [Abstract][Full Text] [Related]
7. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications.
Henning NJ; Manford AG; Spradlin JN; Brittain SM; Zhang E; McKenna JM; Tallarico JA; Schirle M; Rape M; Nomura DK
J Am Chem Soc; 2022 Jan; 144(2):701-708. PubMed ID: 34994556
[TBL] [Abstract][Full Text] [Related]
9. Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB.
King EA; Cho Y; Hsu NS; Dovala D; McKenna JM; Tallarico JA; Schirle M; Nomura DK
Cell Chem Biol; 2023 Apr; 30(4):394-402.e9. PubMed ID: 36898369
[TBL] [Abstract][Full Text] [Related]
10. A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL.
Tong B; Spradlin JN; Novaes LFT; Zhang E; Hu X; Moeller M; Brittain SM; McGregor LM; McKenna JM; Tallarico JA; Schirle M; Maimone TJ; Nomura DK
ACS Chem Biol; 2020 Jul; 15(7):1788-1794. PubMed ID: 32568522
[TBL] [Abstract][Full Text] [Related]
11. Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function.
Luo M; Spradlin JN; Boike L; Tong B; Brittain SM; McKenna JM; Tallarico JA; Schirle M; Maimone TJ; Nomura DK
Cell Chem Biol; 2021 Apr; 28(4):559-566.e15. PubMed ID: 33513350
[TBL] [Abstract][Full Text] [Related]
12. Development of Phenyl-substituted Isoindolinone- and Benzimidazole-type Cereblon Ligands for Targeted Protein Degradation.
Nie X; Zhao Y; Tang H; Zhang Z; Liao J; Almodovar-Rivera CM; Sundaresan R; Xie H; Guo L; Wang B; Guan H; Xing Y; Tang W
Chembiochem; 2024 Feb; 25(4):e202300685. PubMed ID: 38116854
[TBL] [Abstract][Full Text] [Related]
13. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
Ishida T; Ciulli A
SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
[TBL] [Abstract][Full Text] [Related]
14. Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs.
Shah RR; De Vita E; Sathyamurthi PS; Conole D; Zhang X; Fellows E; Dickinson ER; Fleites CM; Queisser MA; Harling JD; Tate EW
J Med Chem; 2024 Mar; 67(6):4641-4654. PubMed ID: 38478885
[TBL] [Abstract][Full Text] [Related]
15. TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains.
Kaiho-Soma A; Akizuki Y; Igarashi K; Endo A; Shoda T; Kawase Y; Demizu Y; Naito M; Saeki Y; Tanaka K; Ohtake F
Mol Cell; 2021 Apr; 81(7):1411-1424.e7. PubMed ID: 33567268
[TBL] [Abstract][Full Text] [Related]
16. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera.
Kim K; Lee DH; Park S; Jo SH; Ku B; Park SG; Park BC; Jeon YU; Ahn S; Kang CH; Hwang D; Chae S; Ha JD; Kim S; Hwang JY; Kim JH
Sci Rep; 2019 Dec; 9(1):19654. PubMed ID: 31873151
[TBL] [Abstract][Full Text] [Related]
17. Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16.
Zhang X; Crowley VM; Wucherpfennig TG; Dix MM; Cravatt BF
Nat Chem Biol; 2019 Jul; 15(7):737-746. PubMed ID: 31209349
[TBL] [Abstract][Full Text] [Related]
18. Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins.
Yokoo H; Tsuji G; Inoue T; Naito M; Demizu Y; Ohoka N
Bioorg Chem; 2024 Apr; 145():107204. PubMed ID: 38377822
[TBL] [Abstract][Full Text] [Related]
19. PROTACs: A novel strategy for cancer drug discovery and development.
Han X; Sun Y
MedComm (2020); 2023 Jun; 4(3):e290. PubMed ID: 37261210
[TBL] [Abstract][Full Text] [Related]
20. Small molecule NSC1892 targets the CUL4A/4B-DDB1 interactions and causes impairment of CRL4
Yang C; Wu J; He H; Liu H
Int J Biol Sci; 2020; 16(6):1059-1070. PubMed ID: 32140073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]